Jiangsu Hengrui Medicine Co., Ltd. Jiangsu Hengrui Medicine Co., Ltd.

Jiangsu Hengrui Medicine Co., Ltd.

600276

주식 순위 #544
Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged... Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged in the full spectrum of pharmaceutical operations, from the initial discovery and development of medications to their manufacturing and worldwide distribution. The company is actively advancing a substantial pipeline of drug candidates, which includes Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403. These prospective treatments are aimed at a diverse range of medical conditions, primarily focusing on oncology, metabolic disorders, pain management, and autoimmune diseases, among others. The enterprise was founded in 1970 and maintains its corporate headquarters in Lianyungang, China.
주가
$6.89
시가총액
$43.94B
변동 (1일)
-2.91%
변동 (1년)
-24.78%
국가
CN
거래 Jiangsu Hengrui Medicine Co., Ltd. (600276)

카테고리

Healthcare
Jiangsu Hengrui Medicine Co., Ltd. (600276)의 주식 분할 이력
Jiangsu Hengrui Medicine Co., Ltd. 주식 (심볼: 600276)은 총 19회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Jun 10, 2021에 발생했습니다.
May 11, 2001 이전에 매수한 600276 주식 1주는 현재 47.810942329106주의 600276 주식에 해당합니다.
주식 분할 목록
연도 주식 분할 배수 누적 배수
2021-06-10 6:5 x1.2 x47.810942329106
2020-05-25 6:5 x1.2 x39.842451940921
2019-03-28 6:5 x1.2 x33.202043284101
2018-05-30 13:10 x1.3 x27.668369403418
2017-05-31 6:5 x1.2 x21.283361079552
2016-06-16 6:5 x1.2 x17.73613423296
2015-06-15 13:10 x1.3 x14.7801118608
2014-05-15 11:10 x1.1 x11.369316816
2013-06-07 11:10 x1.1 x10.33574256
2012-05-29 11:10 x1.1 x9.3961296
2011-04-26 3:2 x1.5 x8.541936
2010-03-17 6:5 x1.2 x5.694624
2009-04-30 6:5 x1.2 x4.74552
2008-04-11 6:5 x1.2 x3.9546
2007-04-02 13:10 x1.3 x3.2955
2006-08-29 13:10 x1.3 x2.535
2006-06-19 5:4 x1.25 x1.95
2002-05-21 6:5 x1.2 x1.56
2001-05-11 13:10 x1.3 x1.3
유사 기업 또는 경쟁사의 주식 분할